XML 19 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:    
Net income $ 6,653,000 $ 2,886,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Gain on sale of real estate, net (2,408,000)  
Increase in unbilled rent receivable (287,000) (203,000)
Write-off of unbilled rent receivable   263,000
Bad debt expense   296,000
Amortization of intangibles relating to leases, net (240,000) (246,000)
Amortization of restricted stock expense 826,000 742,000
Equity in earnings of unconsolidated joint ventures (195,000) (245,000)
Distributions of earnings from unconsolidated joint ventures 51,000 222,000
Depreciation and amortization 5,182,000 5,553,000
Amortization and write-off of deferred financing costs 228,000 227,000
Payment of leasing commissions (8,000)  
Decrease (increase) in escrow, deposits, other assets and receivables 160,000 (143,000)
(Decrease) increase in accrued expenses and other liabilities (20,000) 500,000
Net cash provided by operating activities 9,942,000 9,852,000
Cash flows from investing activities:    
Purchase of real estate (12,900,000)  
Improvements to real estate (5,231,000) (412,000)
Net proceeds from sale of real estate 8,958,000  
Distributions of capital from unconsolidated joint ventures   111,000
Net cash used in investing activities (9,173,000) (301,000)
Cash flows from financing activities:    
Scheduled amortization payments of mortgages payable (2,662,000) (2,551,000)
Repayment of mortgages payable (9,099,000)  
Proceeds from mortgage financings 7,900,000  
Proceeds from sale of common stock, net   635,000
Proceeds from bank line of credit 20,000,000  
Repayment on bank line of credit (8,500,000) (5,000,000)
Issuance of shares through dividend reinvestment plan 1,181,000 972,000
Payment of financing costs (164,000) 160,000
Distributions to non-controlling interests (1,082,000) (31,000)
Cash distributions to common stockholders (8,493,000) (7,806,000)
Net cash used in financing activities (919,000) (13,621,000)
Net decrease in cash, cash equivalents and restricted cash (150,000) (4,070,000)
Cash, cash equivalents, and restricted cash at beginning of year 14,668,000 18,450,000
Cash, cash equivalents, and restricted cash at end of year 14,518,000 14,380,000
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest expense $ 4,297,000 $ 4,323,000